Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 157

1.

Epidemiology and risk factors for perioperative mortality after total hip and knee arthroplasty.

Memtsoudis SG, Pumberger M, Ma Y, Chiu YL, Fritsch G, Gerner P, Poultsides L, Valle AG.

J Orthop Res. 2012 Nov;30(11):1811-21. doi: 10.1002/jor.22139. Epub 2012 Apr 19.

2.

Trends in in-hospital major morbidity and mortality after total joint arthroplasty: United States 1998-2008.

Kirksey M, Chiu YL, Ma Y, Della Valle AG, Poultsides L, Gerner P, Memtsoudis SG.

Anesth Analg. 2012 Aug;115(2):321-7. doi: 10.1213/ANE.0b013e31825b6824. Epub 2012 May 31.

PMID:
22652311
3.

Perioperative mortality in patients with pulmonary hypertension undergoing major joint replacement.

Memtsoudis SG, Ma Y, Chiu YL, Walz JM, Voswinckel R, Mazumdar M.

Anesth Analg. 2010 Nov;111(5):1110-6. doi: 10.1213/ANE.0b013e3181f43149. Epub 2010 Sep 14.

PMID:
20841415
4.

Rheumatoid arthritis patients undergoing total hip and knee arthroplasty have better in-hospital outcomes compared with non-rheumatoid arthritis patients.

Yoshihara H, Yoneoka D, Margalit A, Zuckerman JD.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2):270-5. Epub 2016 Feb 9.

PMID:
26886847
5.

Ninety-day mortality in patients undergoing elective total hip or total knee arthroplasty.

Singh JA, Lewallen DG.

J Arthroplasty. 2012 Sep;27(8):1417-1422.e1. doi: 10.1016/j.arth.2012.03.008. Epub 2012 May 2.

6.

Hospital volume and surgical outcomes after elective hip/knee arthroplasty: a risk-adjusted analysis of a large regional database.

Singh JA, Kwoh CK, Boudreau RM, Lee GC, Ibrahim SA.

Arthritis Rheum. 2011 Aug;63(8):2531-9. doi: 10.1002/art.30390.

7.

Is decreasing mortality in total hip and knee arthroplasty patients dependent on patients' comorbidity?

Glassou EN, Pedersen AB, Hansen TB.

Acta Orthop. 2017 Jun;88(3):288-293. doi: 10.1080/17453674.2017.1279496. Epub 2017 Jan 12.

8.

Does sickle cell disease increase risk of adverse outcomes following total hip and knee arthroplasty? A nationwide database study.

Perfetti DC, Boylan MR, Naziri Q, Khanuja HS, Urban WP.

J Arthroplasty. 2015 Apr;30(4):547-51. doi: 10.1016/j.arth.2014.10.035. Epub 2014 Nov 11.

PMID:
25496931
9.

National trends in the utilization of blood transfusions in total hip and knee arthroplasty.

Yoshihara H, Yoneoka D.

J Arthroplasty. 2014 Oct;29(10):1932-7. doi: 10.1016/j.arth.2014.04.029. Epub 2014 Apr 26.

PMID:
24890994
10.

Development and Validation of Perioperative Risk-Adjustment Models for Hip Fracture Repair, Total Hip Arthroplasty, and Total Knee Arthroplasty.

Schilling PL, Bozic KJ.

J Bone Joint Surg Am. 2016 Jan 6;98(1):e2. doi: 10.2106/JBJS.N.01330.

PMID:
26738909
11.

Comparative Epidemiology of Revision Arthroplasty: Failed THA Poses Greater Clinical and Economic Burdens Than Failed TKA.

Bozic KJ, Kamath AF, Ong K, Lau E, Kurtz S, Chan V, Vail TP, Rubash H, Berry DJ.

Clin Orthop Relat Res. 2015 Jun;473(6):2131-8. doi: 10.1007/s11999-014-4078-8. Epub 2014 Dec 3.

12.

Risk factors for perioperative mortality after lower extremity arthroplasty: a population-based study of 6,901,324 patient discharges.

Memtsoudis SG, Della Valle AG, Besculides MC, Esposito M, Koulouvaris P, Salvati EA.

J Arthroplasty. 2010 Jan;25(1):19-26. doi: 10.1016/j.arth.2008.11.010. Epub 2008 Dec 23.

PMID:
19106028
13.

Predictors of allogeneic blood transfusion in total hip and knee arthroplasty in the United States, 2000-2009.

Yoshihara H, Yoneoka D.

J Arthroplasty. 2014 Sep;29(9):1736-40. doi: 10.1016/j.arth.2014.04.026. Epub 2014 Apr 26.

PMID:
24891002
14.

Benefit-risk assessment of rivaroxaban versus enoxaparin for the prevention of venous thromboembolism after total hip or knee arthroplasty.

Levitan B, Yuan Z, Turpie AG, Friedman RJ, Homering M, Berlin JA, Berkowitz SD, Weinstein RB, DiBattiste PM.

Vasc Health Risk Manag. 2014 Mar 26;10:157-67. doi: 10.2147/VHRM.S54714. eCollection 2014.

15.

Perioperative outcomes after unilateral and bilateral total knee arthroplasty.

Memtsoudis SG, Ma Y, González Della Valle A, Mazumdar M, Gaber-Baylis LK, MacKenzie CR, Sculco TP.

Anesthesiology. 2009 Dec;111(6):1206-16. doi: 10.1097/ALN.0b013e3181bfab7d.

16.

Cardiac and thromboembolic complications and mortality in patients undergoing total hip and total knee arthroplasty.

Singh JA, Jensen MR, Harmsen WS, Gabriel SE, Lewallen DG.

Ann Rheum Dis. 2011 Dec;70(12):2082-8. doi: 10.1136/ard.2010.148726. Epub 2011 Oct 21.

17.

The John Insall Award: Morbid obesity independently impacts complications, mortality, and resource use after TKA.

D'Apuzzo MR, Novicoff WM, Browne JA.

Clin Orthop Relat Res. 2015 Jan;473(1):57-63. doi: 10.1007/s11999-014-3668-9.

18.

Does BMI affect perioperative complications following total knee and hip arthroplasty?

Suleiman LI, Ortega G, Ong'uti SK, Gonzalez DO, Tran DD, Onyike A, Turner PL, Fullum TM.

J Surg Res. 2012 May 1;174(1):7-11. doi: 10.1016/j.jss.2011.05.057. Epub 2011 Jun 25.

PMID:
21816426
19.

Comparison of US and Canadian Perioperative Outcomes and Hospital Efficiency After Total Hip and Knee Arthroplasty.

Hart A, Bergeron SG, Epure L, Huk O, Zukor D, Antoniou J.

JAMA Surg. 2015 Oct;150(10):990-8. doi: 10.1001/jamasurg.2015.1239.

PMID:
26288005
20.

Supplemental Content

Support Center